NEWMarkets

Rapport Therapeutics stock reaches all-time high of 42.36 USD

Published on 6/30/2026

#RAPT#stocks#markets#biotech
Rapport Therapeutics stock reaches all-time high of 42.36 USD

AI Summary

Rapport Therapeutics (RAPT) has reached an all-time high stock price of 42.36 USD. This significant milestone indicates strong investor interest and may influence market perceptions of the company's growth potential. The rise in stock price could attract more traders and investors looking for profitable opportunities. Understanding patterns like this can provide insights into market trends for biotech stocks.

Source: Read original article (opens in new tab)

Related News

Form 144 Credit Acceptance Corp Data Revealed on 30 June
Markets

Form 144 Credit Acceptance Corp Data Revealed on 30 June

Jun 30

PEDEVCO CORP (PED) Form 144 Submission Data for June 30
Markets

PEDEVCO CORP (PED) Form 144 Submission Data for June 30

Jun 30

Oscar Health Inc (OSCR) Form 4 Filing Reported June 30
Markets

Oscar Health Inc (OSCR) Form 4 Filing Reported June 30

Jun 30

FDA Questions Kennedy-Backed Peptides Ahead of Advisory Panel Review
Regulation

FDA Questions Kennedy-Backed Peptides Ahead of Advisory Panel Review

Jun 30